Editorial
doi: 10.1016/j.jcin.2008.09.006.
Resisting the temptation to oversimplify antiplatelet resistance
- PMID: 19463381
- DOI: 10.1016/j.jcin.2008.09.006
Item in Clipboard
Editorial
Resisting the temptation to oversimplify antiplatelet resistance
JACC Cardiovasc Interv.
2008 Dec.
Free article
No abstract available
Comment on
-
Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.JACC Cardiovasc Interv. 2008 Dec;1(6):649-53. doi: 10.1016/j.jcin.2008.08.018. JACC Cardiovasc Interv. 2008. PMID: 19463379 Clinical Trial.
-
The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy.JACC Cardiovasc Interv. 2008 Dec;1(6):654-9. doi: 10.1016/j.jcin.2008.08.017. JACC Cardiovasc Interv. 2008. PMID: 19463380 Clinical Trial.
Similar articles
-
The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.Rev Cardiovasc Med. 2006;7 Suppl 4:S20-8. Rev Cardiovasc Med. 2006. PMID: 17224887 Review.
-
Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.JACC Cardiovasc Interv. 2008 Dec;1(6):649-53. doi: 10.1016/j.jcin.2008.08.018. JACC Cardiovasc Interv. 2008. PMID: 19463379 Clinical Trial.
-
Platelet function testing and implications for clinical practice.J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):157-69. doi: 10.1177/1074248409339309. J Cardiovasc Pharmacol Ther. 2009. PMID: 19721130 Review.
-
Effects of GP IIb/IIIa inhibitors on vascular inflammation, coronary microcirculation, and platelet function.Rev Cardiovasc Med. 2006;7 Suppl 4:S3-11. Rev Cardiovasc Med. 2006. PMID: 17224889 Review.
-
Is heparin an acceptable anticoagulant when glycoprotein IIb/IIIa inhibitors are not used?JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):223-224. doi: 10.1016/j.jcin.2014.07.019. Epub 2014 Nov 1. JACC Cardiovasc Interv. 2015. PMID: 25616929 No abstract available.
Cited by
-
Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence.Nat Rev Cardiol. 2010 Aug;7(8):461-7. doi: 10.1038/nrcardio.2010.71. Epub 2010 Jun 1. Nat Rev Cardiol. 2010. PMID: 20517286 Review.
-
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence study.J Thromb Thrombolysis. 2019 Nov;48(4):554-562. doi: 10.1007/s11239-019-01933-7. J Thromb Thrombolysis. 2019. PMID: 31420787 Free PMC article. Clinical Trial.
-
The evolution of antiplatelet therapy in cardiovascular disease.Nat Rev Cardiol. 2011 Jul 12;8(10):547-59. doi: 10.1038/nrcardio.2011.96. Nat Rev Cardiol. 2011. PMID: 21750497 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
